Nanomedicines for Receptor-Mediated Tumor Targeting

Publisher： Bentham Science Publishers

E-ISSN： 1877-9131|1|2|138-148

ISSN： 1877-9123

Source： Recent Patents on Nanomedicine, Vol.1, Iss.2, 2011-12, pp. : 138-148

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nanomedicines for Brain Targeting: A Patent Review

By  

Recent Patents on Nanomedicine, Vol. 1, Iss. 2, 2011-01 ,pp. : 149-161

Bentham Science Publishers

Access to resources Recommend Favorite

T-Cell Receptor-Mediated Cross-Allergenicity

By  

International Archives of Allergy and Immunology, Vol. 135, Iss. 4, 2004-12 ,pp. : 296-305

Karger

Access to resources Recommend Favorite

Transferrin-mediated targeting of bacteriophage HK97 nanoparticles into tumor cells

By Huang Rick K   Steinmetz Nicole F   Fu Chi-Yu   Manchester Marianne   Johnson John E  

Nanomedicine, Vol. 6, Iss. 1, 2011-01 ,pp. : 55-68

Future Medicine

Access to resources Recommend Favorite

Transient receptor potential channels as molecular substrates of receptor-mediated cation entry

By Hofmann Thomas   Schaefer Michael   Schultz Günter   Gudermann Thomas  

Journal of Molecular Medicine, Vol. 78, Iss. 1, 2000-01 ,pp. : 14-25

Springer Publishing Company

Access to resources Recommend Favorite

Ontogeny of NMDA receptor-mediated morphine tolerance in the postnatal rat

By Zhu H.   Barr G.A.  

Pain, Vol. 104, Iss. 3, 2003-08 ,pp. : 437-447

Elsevier

Access to resources Recommend Favorite